Pfizer announced on Tuesday that it has filed for U.S. authorization of the company’s new antiviral Covid-19 pill. The pill, called Paxlovid, has yielded impressive results in clinical trials, reducing hospitalization or death by 89%. If approved, the drug could prove to be a gamechanger for those most vulnerable to severe illness, as well as […] Read the full story on GreekReporter.com.
 |
| READ THE ORIGINAL POST AT greekreporter.com |
